BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 33523452)

  • 1. TNF-TNFR2 Signal Plays a Decisive Role in the Activation of CD4
    Islam MS; Yang Y; Chen X
    Adv Exp Med Biol; 2021; 1278():257-272. PubMed ID: 33523452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNFR2-expressing CD4
    He J; Li R; Chen Y; Hu Y; Chen X
    Prog Mol Biol Transl Sci; 2019; 164():101-117. PubMed ID: 31383403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Significance of Tumor Necrosis Factor Receptor Type II in CD8
    Ye LL; Wei XS; Zhang M; Niu YR; Zhou Q
    Front Immunol; 2018; 9():583. PubMed ID: 29623079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications.
    Yang S; Wang J; Brand DD; Zheng SG
    Front Immunol; 2018; 9():784. PubMed ID: 29725328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of TNFα-TNFR1 and TNFα-TNFR2 in the differentiation and function of CD4
    Yang S; Xie C; Chen Y; Wang J; Chen X; Lu Z; June RR; Zheng SG
    Cell Death Dis; 2019 Jan; 10(1):27. PubMed ID: 30631042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents.
    Zou H; Li R; Hu H; Hu Y; Chen X
    Front Immunol; 2018; 9():594. PubMed ID: 29632537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo.
    Zhou Q; Hu Y; Howard OM; Oppenheim JJ; Chen X
    Cytokine; 2014 Jan; 65(1):56-64. PubMed ID: 24080164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling pathway(s) of TNFR2 required for the immunoregulatory effect of CD4
    He T; Zhao Y; Zhao P; Zhao L; Zakaria J; Wang K
    Int Immunopharmacol; 2022 Jul; 108():108823. PubMed ID: 35623290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment.
    Chen X; Wu X; Zhou Q; Howard OM; Netea MG; Oppenheim JJ
    J Immunol; 2013 Feb; 190(3):1076-84. PubMed ID: 23277487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
    Wang M; Zhang C; Tian T; Zhang T; Wang R; Han F; Zhong C; Hua M; Ma D
    Front Immunol; 2018; 9():1274. PubMed ID: 29922294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells.
    Chen X; Oppenheim JJ
    Curr Dir Autoimmun; 2010; 11():119-34. PubMed ID: 20173391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4
    Chen S; Li R; Chen Y; Chou CK; Zhang Z; Yang Y; Liao P; Wang Q; Chen X
    Biomed Pharmacother; 2022 Jul; 151():113187. PubMed ID: 35676787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential Expansion of CD4
    Chou CK; Chen X
    Methods Mol Biol; 2020; 2111():71-78. PubMed ID: 31933199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ Foxp3+ Regulatory T-cells in Modulating Inflammatory Microenvironment in Chronic Rhinosinusitis with Nasal Polyps: Progress and Future Prospect.
    M Yusoff NNF; Ahmad S; Wan Abdul Rahman WF; Mohamud R; C Boer J; Plebanski M; Abdullah B; Chen X; Tengku Din TADA
    Cytokine; 2024 Jun; 178():156557. PubMed ID: 38452440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bivalent structure of a TNFR2-selective and agonistic TNF-α mutein Fc-fusion protein enhances the expansion activity of regulatory T cells.
    Inoue M; Tsuji Y; Ueno R; Miyamoto D; Tanaka K; Moriyasu Y; Shibata S; Okuda M; Ando D; Abe Y; Kamada H; Tsunoda SI
    Sci Rep; 2023 Aug; 13(1):13762. PubMed ID: 37612373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4
    He T; Yang D; Li XQ; Jiang M; Islam MS; Chen S; Chen Y; Yang Y; Chou CK; Trivett AL; Oppenheim JJ; Chen X
    Sci Adv; 2020 Sep; 6(40):. PubMed ID: 32998896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells.
    Chen X; Hamano R; Subleski JJ; Hurwitz AA; Howard OM; Oppenheim JJ
    J Immunol; 2010 Jul; 185(1):174-82. PubMed ID: 20525892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4
    He T; Chen Y; Yang D; Islam MS; Chou CK; Liu J; Faustman DL; Oppenheim JJ; Chen X
    Cell Oncol (Dordr); 2023 Feb; 46(1):167-177. PubMed ID: 36369606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p38 MAPK Inhibitor SB203580 Abrogates Tumor Necrosis Factor-Induced Proliferative Expansion of Mouse CD4
    He T; Liu S; Chen S; Ye J; Wu X; Bian Z; Chen X
    Front Immunol; 2018; 9():1556. PubMed ID: 30038619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical Application of Tetrandrine Nanoemulsion Promotes the Expansion of CD4
    Chen S; Lin Z; He T; Islam MS; Xi L; Liao P; Yang Y; Zheng Y; Chen X
    Front Immunol; 2022; 13():800283. PubMed ID: 35464441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.